Clinical Trials
2 trialsNCT00072618 2011-10-20
Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
Astellas Pharma Inc
Phase 1/2 Completed
NCT00085826 2011-10-20
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
Astellas Pharma Inc
Phase 3 Completed